Dysgerminoma: Clinical Trials

3 trials for Dysgerminoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Dysgerminoma: new trials by email Literature Review of Dysgerminoma trials Research Report on Dysgerminoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
sunitinib malate - Extragonadal Germ Cell Tumor, Ovarian Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center102007-03-012015-10-27
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
pegfilgrastim, cisplatin, ifosfamide - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center602007-03-012017-11-28
Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
Darbepoetin alfa - Dysgerminoma
Phase 2CompletedUniversity Hospital Tuebingen1082003-07-012009-02-16

Narrower conditions

Carcinoma, Embryonal (2)  ·  Endodermal Sinus Tumor (2)  ·  Ovarian Neoplasms (2)  ·  Seminoma (2)  ·  Teratoma (2)  ·  Testicular Germ Cell Tumor (2)  ·  Testicular Neoplasms (2)  ·  Central Nervous System Neoplasms (1)

Broader conditions

Germinoma (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Adnexal Diseases (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Female (2)  ·  Genital Neoplasms, Male (2)  ·  Gonadal Disorders (2)

Interventions

Cisplatin (1)  ·  Darbepoetin alfa (1)  ·  Ifosfamide (1)  ·  Paclitaxel (1)  ·  Sunitinib (1)  ·  pegfilgrastim (1)

Sponsors

Memorial Sloan Kettering Cancer Center (2)  ·  University Hospital Tuebingen (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Robert J. Motzer, MD (2)  ·  Darren Feldman, MD (1)  ·  Dean F. Bajorin, MD (1)  ·  Joerg T. Hartmann, MD (1)

Results publications

PMID 19547919

NIH funding

P30CA008748 (1)